Publications by authors named "Yihe Yan"

Claim this Profile
S
Study on the regulation of renal tubular cell apoptosis by SIRT1/NF-κB signaling pathway in septic acute kidney injury.
Weiwei Chu, Xuedong Sun, Yihe Yan

Ren Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study.
Da-Long Yang, Ning Peng, Jun-Liang Nong, Kang Chen, Ze Su, Yi-He Yan, Fu-Quan Yang, Yong-Yu Yang

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: A comparative analysis in a real-world cohort.
Yangyang Ou, Yiyu Chen, Kang Chen, Ming Yao, Guanglin Ling, Yanlong Liu, Yihe Yan

Am J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shape Memory-Driven Intelligent Composite Film for Infrared Stealth and Adjustable EMI Shielding.
Yang Bai, Jiayi Ju, Yujie Pan, Boyuan Zhang, Yihe Yan

Small· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004).
Da-Long Yang, Yi-He Yan, Yong-Cheng Lai, Ming-Song Wu, Xiao-Feng Dong, Fu-Quan Yang, Yong-Yu Yang

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of hepatic artery interventional therapies in the conversion treatment of unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Yongchao Zeng, Zhiqiang Wang, Shixun Lin, Yihe Yan

Am J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Yi-He Yan, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Yi-He Yan, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICA+ Tumor Cells Modulate Macrophage Phenotype and Function via PPAR/EHHADH-Mediated Fatty Acid Metabolism in Hepatocellular Carcinoma (HCC).
Jingquan Huang, Yumeng Teng, Peng Yan, Yan Yang, Shixun Lin, Yihe Yan

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Regulation in Acute Respiratory Distress Syndrome: Implications for Inflammation and Oxidative Stress.
Lixia Yue, Yihe Yan

Int J Chron Obstruct Pulmon Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC.
Qiulin Wu, Yan Yang, Shixun Lin, David A Geller, Yihe Yan

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma.
Zhaosong Xue, Ming Yao, Kang Chen, Taiyun Huang, Jianjun Li, Yihe Yan

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bidirectional two-sample Mendelian randomization study to evaluate the relationship between psoriasis and interstitial lung diseases.
Lixia Yue, Yihe Yan, Shushan Zhao

BMC Pulm Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors analyses associated with postoperative infection in choledochoscopy for intrahepatic bile duct stones (IHDs): a single-center retrospective study in real-world setting.
Yangyang Ou, Jianjun Li, Chunfeng Liang, Chongyuan Hu, Ming Yao, Yihe Yan

Surg Endosc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC).
Qiulin Wu, Xicai Li, Yan Yang, Jingquan Huang, Ming Yao, Yihe Yan

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of methylprednisolone combined with advanced antibiotics and antiviral drugs on serum immunoglobulin and inflammatory factor levels in patients with viral pneumonia.
Lixia Yue, Yihe Yan

Cell Mol Biol (Noisy-le-grand)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors and Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma.
Yangyang Ou, Tao Liu, Taiyun Huang, Zhaosong Xue, Ming Yao, Yihe Yan

J Laparoendosc Adv Surg Tech A· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC).
Jingquan Huang, Qiulin Wu, David A Geller, Yihe Yan

J Transl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCNN1B regulates the proliferation, migration, and collagen deposition of human lung fibroblasts.
Yihe Yan, Yiting Zhang, Juanqi Zhang, Lijun Ying

In Vitro Cell Dev Biol Anim· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delimiting Low Level of Difficulty Scoring System Based on the Extent of Resection Difficulty Scoring System for Laparoscopic Liver Resection.
Tao Liu, Yangyang Ou, Taiyun Huang, Zhaosong Xue, Ming Yao, Yihe Yan

J Laparoendosc Adv Surg Tech A· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages.
Xiao Cui, Huiyong Zhao, Sheng Wei, Qiang Du, Kun Dong, Yihe Yan

Neoplasia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC).
Xicai Li, Jingquan Huang, Qiulin Wu, Qiang Du, Yingyu Wang, Yihe Yan

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-γ/IRF-1 pathway regulatory mechanisms of PD-L1 expression and relevance for immune checkpoint blockade in hepatocellular carcinoma (HCC).
Yihe Yan, Leting Zheng, Qiang Du, David A Geller

Oncotarget· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells.
Yihe Yan, Leting Zheng, Qiang Du, Xiao Cui, Kun Dong

Br J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin.
Yarong Guo, Jun Xu, Qiang Du, Yihe Yan, David A Geller

Transl Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis